Development of a 5-hydroxytryptamine(2A) receptor binding assay for high throughput screening using 96-well microfilter plates

Journal of Biomolecular Screening

Volumn 5, Issue 4, 2000, Pages 269-277

  Harms, Antje ^a   Gundisch, Daniela ^b   Muller, Christa E ^b   Kovar, Karl Artur ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

KETANSERIN; POLYETHYLENEIMINE; PROTEIN; RADIOLIGAND; SEROTONIN 2A RECEPTOR;

ACCURACY; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; BINDING KINETICS; BIOFILTER; CONCENTRATION RESPONSE; CONTROLLED STUDY; FRONTAL CORTEX; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; REACTION ANALYSIS; RECEPTOR BINDING; SCINTILLATION CAMERA; SCINTILLATION COUNTING; STOICHIOMETRY;

ANIMALIA;

EID: 0033822414     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1177/108705710000500410     Document Type: Article

References (40)

1. Chemistry and pharmacology of hallucinogens, entactogens and stimulants
2. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists
3. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents
4. Hallucinogenic and serotonergic mechanisms
5. 2,3-Dihydrobenzofuran analogues of hallucinogenic phenethylamines
6. 1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: A potent serotonin 5-HT(2A/2C) agonist
7. Serotonergic neurons and 5-HT receptors in the CNS
8. Receptor pharmacology of MDMA and related hallucinogens
9. Antagonist properties of d-LSD at 5-hydroxytryptamine2 receptors
10. Do classical hallucinogens act as 5-HT2 agonists or antagonists?
11. 2 serotonin receptors: Evidence for a lack of selectivity
12. Influence of amine substituents on 5-HT(2A) versus 5-HT(2C) binding of phenylalkyl- and indolylalkylamines
13. Hallucinogenic drug interactions at human brain 5-HT2 receptors: Implications for treating LSD-induced hallucinogenesis
14. VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
15. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors
16. 3H-ligand for serotonin2 receptor binding sites: Binding properties, brain distribution, and functional role
17. 3H]ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor
18. 2 receptors
19. Development of nonseparation binding and functional assays for G-protein-coupled receptors for high throughput screening: Pharmacological characterization of the immobilized CCR5 receptor on FlashPlate®
20. 35S]GTPγS binding to Chinese hamster ovary cell membranes expressing the cloned human 5-HT(1B) receptor
21. Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: Application to anandamide
22. 5-HT(2A)-Radioligand-Rezeptor-Bindungsstudien zur Untersuchung der Struktur-Wirkungs-Beziehungen von halluzinogenen Designer Drogen: Entwicklung einer Hochdurchsatz-Screening-Methode
23. Protein measurement with the Folin Phenol Reagent
24. A simplification of the protein assay method of Lowry et al. which is more generally applicable
25. 50) of an enzymatic reaction
26. Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groups
27. Stereoselective LSD-like activity in a series of d-lysergic acid amides of (R)- and (S)-2-aminoalkanes
28. Effect of a chiral 4-alkyl substituent in hallucinogenic amphetamines
29. 2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues
30. 2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA)
31. Guanyl nucleotide and divalent cation regulation of cortical S2 serotonin receptors
32. 2 and 5-HT(1C) serotonin receptor binding
33. 2 serotonin receptors
34. A rapid filtration assay for soluble receptors using polyethylenimine-treated filters
35. 2 receptors-analysis by quantitative structure-activity relationships
36. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity
37. (+)-1-(2,5-Dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2), a novel putative anxiolytic agent lacking affinity for benzodiazepine sites and serotonin-1A receptors
38. Receptor pharmacology of MDMA and related hallucinogens
39. 2 binding characteristics with phenylalkylamine hallucinogens